{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:46:42Z","timestamp":1791406002042,"version":"4.3.3"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2130,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Numerous anti-hepatitis C virus (HCV) drugs targeting either the viral nonstructural 3 (NS3) protease or NS5B polymerase are currently in clinical testing. However, rapid resistance development is a major problem and optimal therapy will clearly require a combination of multiple mechanisms of action. Cyclosporine A (CsA) and its nonimmunosuppressant derivatives are among the more promising drugs under development. Based on work with subgenomic HCV replicons it has been thought that they act as NS5B-inhibitors. In this study we show that CsA inhibits replication of full-length HCV <jats:italic toggle=\"yes\">Japanese Fulminant Hepatitis<\/jats:italic> (JFH1) genomes about 10-fold more efficiently than subgenomic replicons. This effect is dependent on the presence of NS2 in the viral polyprotein and mediated through cellular cyclophilin A. NS2 is either an additional target for CsA-dependent inhibition or modulates the antiviral activity against NS3 to NS5B proteins. CsA is thus the first anti-HCV drug shown to act through NS2. <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic> CsA inhibits replication of JFH1 full-length genomes much more efficiently than subgenomic replicons by targeting cleavage at the NS2\/NS3 junction and possibly other nonreplication lifecycle steps. (Hepatology 2009.)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.23281","type":"journal-article","created":{"date-parts":[[2009,9,9]],"date-time":"2009-09-09T14:15:21Z","timestamp":1252505721000},"page":"1638-1645","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":118,"title":["Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A #"],"prefix":"10.1097","volume":"50","author":[{"given":"Sandra","family":"Ciesek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Tautz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Bartenschlager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"von Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pietschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-35-20241201","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hep.20819","article-title":"Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes.","volume":"42","author":"Simmonds","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R2-35-20241201","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.","volume":"285","author":"Lohmann","year":"1999","journal-title":"Science"},{"key":"R3-35-20241201","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1073\/pnas.0810950106","article-title":"Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3.","volume":"106","author":"Schregel","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R4-35-20241201","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1073\/pnas.0504877103","article-title":"Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.","volume":"103","author":"Pietschmann","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R5-35-20241201","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.virusres.2007.02.022","article-title":"Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture.","volume":"127","author":"Bartenschlager","year":"2007","journal-title":"Virus Res"},{"key":"R6-35-20241201","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/jhep.2003.50449","article-title":"Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.","volume":"38","author":"Watashi","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R7-35-20241201","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/hep.21587","article-title":"Evaluation of a cyclophilin inhibitor in hepatitis C virusinfected chimeric mice in vivo.","volume":"45","author":"Inoue","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R8-35-20241201","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1128\/AAC.00310-06","article-title":"NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with alpha interferon.","volume":"50","author":"Ma","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-35-20241201","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/hep.22835","article-title":"The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatmentnaive hepatitis C patients.","volume":"49","author":"Flisiak","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R10-35-20241201","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro.","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R11-35-20241201","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1128\/JVI.02614-07","article-title":"Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro.","volume":"82","author":"Yang","year":"2008","journal-title":"J Virol"},{"key":"R12-35-20241201","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molcel.2005.05.014","article-title":"Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase.","volume":"19","author":"Watashi","year":"2005","journal-title":"Mol Cell"},{"key":"R13-35-20241201","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1128\/JVI.02524-06","article-title":"Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in vitro.","volume":"81","author":"Robida","year":"2007","journal-title":"J Virol"},{"key":"R14-35-20241201","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1371\/journal.ppat.0030103","article-title":"Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions.","volume":"3","author":"Steinmann","year":"2007","journal-title":"PLoS Pathog"},{"key":"R15-35-20241201","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1128\/JVI.80.9.4510-4520.2006","article-title":"Diverse effects of cyclosporine on hepatitis C virus strain replication.","volume":"80","author":"Ishii","year":"2006","journal-title":"J Virol"},{"key":"R16-35-20241201","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1021\/bi00223a003","article-title":"Human and Escherichia coli cyclophilins: sensitivity to inhibition by the immunosuppressant cyclosporin A correlates with a specific tryptophan residue.","volume":"30","author":"Liu","year":"1991","journal-title":"Biochemistry"},{"key":"R17-35-20241201","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/hep.21102","article-title":"The nonimmunosuppressive cyclosporin DEBIO025 is a potent inhibitor of hepatitis C virus replication in vitro.","volume":"43","author":"Paeshuyse","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R18-35-20241201","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hep.21809","article-title":"Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B.","volume":"46","author":"Fernandes","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R19-35-20241201","first-page":"63","article-title":"The hepatitis C virus NS23 protease.","volume":"9","author":"Welbourn","year":"2007","journal-title":"Curr Issues Mol Biol"},{"key":"R20-35-20241201","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nature04975","article-title":"Structure of the catalytic domain of the hepatitis C virus NS2-3 protease.","volume":"442","author":"Lorenz","year":"2006","journal-title":"Nature"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23281","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200911000-00035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:24:52Z","timestamp":1733059492000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200911000-00035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23281","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}